Cel Sci Corporation (CVM)

[lightrock]

@rogue

Ok, but you mention 2017 and Keytruda's first approval was in 2014

And

Aug 5, 2016 Approval FDA Approves Merck’s Keytruda (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

I think a lot of people were trying it before "approved" for specific things